Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Leuk Lymphoma. 2016 Feb 18;57(10):2298–2306. doi: 10.3109/10428194.2016.1144881
Author Contributions Disclosures
DeBoer, R
  • Data analysis

  • Interpretation of data

  • Generation of figures

  • Wrote manuscript

None
Koval, G
  • Performed molecular analysis

  • Collection of data

  • Data analysis

  • Interpretation of data

  • Generation of figures

  • Wrote manuscript

None
Mulkey, F
  • Statistical analysis

  • Interpretation of data

  • Generation of figures

  • Wrote manuscript

None
Wetzler, M
  • Principal Investigator of CALGB 10001

  • Clinical trial design

  • Reviewed manuscript

Consultant for Novartis
Devine, S
  • Clinical trial design

  • Reviewed manuscript

None
Marcucci, G
  • Principal Investigator of CALGB 9665

  • Data analysis

  • Reviewed manuscript

None
Stone, RM
  • Oversaw conduct of clinical trial

  • Reviewed manuscript

None
Larson, RA
  • Oversaw conduct of clinical trial

  • Reviewed manuscript

None
Bloomfield, CD
  • Oversaw cytogenetic analysis

  • Reviewed manuscript

None
Geyer, S
  • Statistical analysis

None
Mullighan, CG
  • Performed molecular analysis

  • Wrote manuscript

None
Stock, W
  • Principal Investigator of CALGB 9862

  • Led present molecular correlative study

  • Oversaw laboratory work

  • Interpretation of data

  • Wrote manuscript

None